Pharmaceuticals, Biotechnology and Life Sciences
Chinese registrational clinical trial for derazantinib to begin in 2H 2019 BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ARQL&src=ctag” target=”_blank”gt;$ARQLlt;/agt; lt;a href=”https://twitter.com/hashtag/arql?src=hash” target=”_blank”gt;#arqllt;/agt;–ArQule, Inc.’s…
Revenuegenerated by Hepatitis A vaccine increased by $12.0 million comparedto same period in 2017, which was offset by $13.6 million decrease in
Based on the source, the market was dominated by the bacteria-basedprobiotic supplements segment, with a 91% share in 2017. Most probioticsupplements include bacterial strains, of which, Lactobacillus sp andBifidobacterium sp are used widely for the maintenance of healthymicrobiota.
DUBLIN–(BUSINESS WIRE)–The “Drug Addiction – Pipeline Review, H1 2019” report has been added to ResearchAndMarkets.com’s offering. Drug Addiction – Pipeline…
DUBLIN–(BUSINESS WIRE)–The “Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026” report has been added to ResearchAndMarkets.com’s offering. “Idiopathic Pulmonary Fibrosis: Competitive…
Inclisiran’s unique profile, vast global market opportunity and long-dated exclusivity set the stage for potentially significant shareholder value creation Independent…
Aptorum Group Limited has established new subsidiary group, Smart Pharma
SMPT token holder will allow them to benefit from the inherent valuationgrowth of SPLP’s intellectual property portfolio
Based on EpimAb’sglobally filed first application, this patent broadly covers bispecificantibodies obtained utilizing the company’s FIT-Ig®technology in a composition of matter claim.
In this pilot project, the Susmed system uses blockchain technology, which isexpected to be more cost-effective than conventional methods inmonitoring of clinical researches and ensuring data accuracy duringmonitoring.